Berapakah harga Aarti Pharmalabs Limited (AARTIPHARM)

Harga Aarti Pharmalabs Limited (AARTIPHARM) adalah $9.28

Apakah topi pasaran Aarti Pharmalabs Limited (AARTIPHARM)

Cap pasaran Aarti Pharmalabs Limited (AARTIPHARM) adalah $841.31M

Aarti Pharmalabs Limited (AARTIPHARM) Hasil Dividen

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Tahun	Hasil Dividen	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Hasil Dividen

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Hasil Dividen	Negara
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	DE
Merck KGaA MRK.DE	0.00%	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	JP
Galderma Group AG GALD.SW	0.00%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	0.83%	IN

Syarikat

Hasil Dividen

Negara